ALIM - ALIMERA SCIENCES INC

QQQ $ 439.55 $ -0.26 (-0.06 %)

DIA $ 390.50 $ 1.74 (0.45 %)

SPY $ 517.10 $ 0.05 (0.01 %)

TLT $ 90.18 $ -0.55 (-0.61 %)

GLD $ 213.58 $ -0.63 (-0.29 %)

Previous Close

$ 3.65

Open

$ 3.66

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 3.60 - $ 3.67

52 Week Range

$ 1.56 - $ 4.38

Volume

35,796

Average Volume

Market Cap

93.3M

Beta (5Y Monthly)

$ 1.34

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	03-08-2024	12-31-2023	10-K
2	11-02-2023	09-30-2023	10-Q
3	08-11-2023	06-30-2023	10-Q
4	05-15-2023	03-31-2023	10-Q
5	03-31-2023	12-31-2022	10-K
6	11-14-2022	09-30-2022	10-Q
7	08-05-2022	06-30-2022	10-Q
8	05-12-2022	03-31-2022	10-Q
9	03-23-2022	12-31-2021	10-K
10	11-05-2021	09-30-2021	10-Q
11	08-16-2021	06-30-2021	10-Q
12	05-07-2021	03-31-2021	10-Q
13	03-05-2021	12-31-2020	10-K
14	11-03-2020	09-30-2020	10-Q
15	08-04-2020	06-30-2020	10-Q
16	05-06-2020	03-31-2020	10-Q
17	03-02-2020	12-31-2019	10-K
18	11-05-2019	09-30-2019	10-Q
19	08-06-2019	06-30-2019	10-Q
20	05-07-2019	03-31-2019	10-Q
21	02-25-2019	12-31-2018	10-K
22	11-09-2018	09-30-2018	10-Q
23	08-02-2018	06-30-2018	10-Q
24	05-09-2018	03-31-2018	10-Q
25	03-02-2018	12-31-2017	10-K
26	11-03-2017	09-30-2017	10-Q
27	08-10-2017	06-30-2017	10-Q
28	05-11-2017	03-31-2017	10-Q
29	03-03-2017	12-31-2016	10-K
30	11-04-2016	09-30-2016	10-Q
31	08-05-2016	06-30-2016	10-Q
32	05-06-2016	03-31-2016	10-Q
33	03-15-2016	12-31-2015	10-K
34	11-09-2015	09-30-2015	10-Q
35	08-10-2015	06-30-2015	10-Q
36	05-11-2015	03-31-2015	10-Q
37	03-13-2015	12-31-2014	10-K
38	11-14-2014	09-30-2014	10-Q
39	08-11-2014	06-30-2014	10-Q
40	05-08-2014	03-31-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Alimera Announces Scientific Data Highligh...
05/07/2024 12:11:28

Alimera Sciences, Inc. (NASDAQ:ALIM) ("Alimera"), a global pharmaceutical company whose mission is to be invaluable to ...

Maxim Group Initiates Coverage On Alimera ...
03/25/2024 12:03:50

Maxim Group analyst Naz Rahman initiates coverage on Alimera Sciences (NASDAQ:ALIM) with a Buy rating and announces Price Ta...

Alimera Announces First Patient Randomized...
03/19/2024 12:05:42

HC Wainwright & Co. Maintains Buy on Alime...
03/08/2024 18:01:12

HC Wainwright & Co. analyst Yi Chen maintains Alimera Sciences (NASDAQ:ALIM) with a Buy and raises the price target from...

Alimera Sciences Expects 2024 Revenue Over...
03/07/2024 12:40:40

Alimera Sciences Q4 EPS $(0.07) Up From $(...
03/07/2024 12:32:27

Alimera Sciences (NASDAQ:ALIM) reported quarterly losses of $(0.07) per share. This is a 87.04 percent increase over losses of ...

Earnings Scheduled For March 7, 2024
03/07/2024 09:49:44

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on rev...

A Preview Of Alimera Sciences's Earnings
03/06/2024 19:02:04

The UK National Institute For Health And C...
02/08/2024 13:01:52

Alimera Sciences, Inc. (NASDAQ:ALIM) ("Alimera"), a global pharmaceutical company whose mission is to be invaluable to ...

Alimera Completes Recruitment For The Sync...
01/04/2024 13:15:16

Alimera Sciences, Inc. (NASDAQ:ALIM) ("Alimera"), a global pharmaceutical company whose mission is to be invaluable to ...

Alimera Sciences Appoints Elliot Maltz As ...
01/02/2024 13:12:14

Alimera Announces Scientific Data Highligh...
10/31/2023 12:08:27

Alimera Sciences, Inc. (NASDAQ:ALIM) ("Alimera"), a global pharmaceutical company whose mission is to be invaluable to ...

Earnings Scheduled For October 26, 2023
10/26/2023 11:20:21

Companies Reporting Before The Bell • TotalEnergies (NYSE:TTE) is likely to report quarterly earnings at $2.57 per share on re...

Alimera Sciences Q3 EPS $(0.06) Vs $(0.75)...
10/26/2023 11:06:26

Alimera Sciences (NASDAQ:ALIM) reported quarterly losses of $(0.06) per share. This is a 92 percent increase over losses of $(0...

Alimera Announces Multiple Presentations H...
10/11/2023 12:07:57

Alimera Sciences, Inc. (NASDAQ:ALIM) ("Alimera"), a global pharmaceutical company whose mission is to be invaluable to ...

On October 3, 2023, Alimera Sciences Appoi...
10/03/2023 11:09:55

https://www.sec.gov/ix?doc=/Archives/edgar/data/1267602/000126760223000116/alim-20231002x8k.htm

The Latest Analyst Ratings for Alimera Sci...
08/14/2023 19:00:18

HC Wainwright & Co. Reiterates Buy on Alim...
08/14/2023 10:39:33

HC Wainwright & Co. analyst Yi Chen reiterates Alimera Sciences (NASDAQ:ALIM) with a Buy and maintains $5 price target.

Alimera Sciences Q2 EPS $(1.32) Misses $0....
08/10/2023 11:32:19

Alimera Sciences (NASDAQ:ALIM) reported quarterly losses of $(1.32) per share which missed the analyst consensus estimate of $0...

Earnings Scheduled For August 10, 2023
08/10/2023 10:59:02

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share o...